BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 28340503)

  • 1. Risk factors for lymph node metastases in women with endometrial cancer: A population-based, nation-wide register study-On behalf of the Swedish Gynecological Cancer Group.
    Stålberg K; Kjølhede P; Bjurberg M; Borgfeldt C; Dahm-Kähler P; Falconer H; Holmberg E; Staf C; Tholander B; Åvall-Lundqvist E; Rosenberg P; Högberg T
    Int J Cancer; 2017 Jun; 140(12):2693-2700. PubMed ID: 28340503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study.
    Stålberg K; Bjurberg M; Borgfeldt C; Carlson J; Dahm-Kähler P; Flöter-Rådestad A; Hellman K; Hjerpe E; Holmberg E; Kjølhede P; Marcickiewicz J; Rosenberg P; Tholander B; Åvall-Lundqvist E; Högberg T
    Acta Oncol; 2019 Nov; 58(11):1628-1633. PubMed ID: 31373248
    [No Abstract]   [Full Text] [Related]  

  • 3. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology.
    Chi DS; Barakat RR; Palayekar MJ; Levine DA; Sonoda Y; Alektiar K; Brown CL; Abu-Rustum NR
    Int J Gynecol Cancer; 2008; 18(2):269-73. PubMed ID: 18334008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer: Overtreatment Is the Main Issue.
    Karalok A; Turan T; Basaran D; Turkmen O; Comert Kimyon G; Tulunay G; Tasci T
    Int J Gynecol Cancer; 2017 May; 27(4):748-753. PubMed ID: 28301338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
    Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
    Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting Model of Lymph Node Metastasis Using Preoperative Tumor Grade, Transvaginal Ultrasound, and Serum CA-125 Level in Patients With Endometrial Cancer.
    Lee J; Kong TW; Paek J; Chang SJ; Ryu HS
    Int J Gynecol Cancer; 2016 Nov; 26(9):1630-1635. PubMed ID: 27654258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomogram to Predict Risk of Lymph Node Metastases in Patients With Endometrioid Endometrial Cancer.
    Pollom EL; Conklin CM; von Eyben R; Folkins AK; Kidd EA
    Int J Gynecol Pathol; 2016 Sep; 35(5):395-401. PubMed ID: 26598977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microcystic, elongated, and fragmented pattern invasion is mainly associated with isolated tumor cell pattern metastases in International Federation of Gynecology and Obstetrics grade I endometrioid endometrial cancer.
    Pelletier MP; Trinh VQ; Stephenson P; Mes-Masson AM; Samouelian V; Provencher DM; Rahimi K
    Hum Pathol; 2017 Apr; 62():33-39. PubMed ID: 27864117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian preservation in young women with endometrial cancer of endometrioid histology.
    Kinjyo Y; Kudaka W; Ooyama T; Inamine M; Nagai Y; Aoki Y
    Acta Obstet Gynecol Scand; 2015 Apr; 94(4):430-4. PubMed ID: 25603833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A modern assessment of the surgical pathologic spread and nodal dissemination of endometrial cancer.
    Praiss AM; Huang Y; St Clair CM; Tergas AI; Melamed A; Khoury-Collado F; Hou JY; Hur C; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Gynecol Oncol; 2020 May; 157(2):329-334. PubMed ID: 32094021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor diameter as a predictor of lymphatic dissemination in endometrioid endometrial cancer.
    Cox Bauer CM; Greer DM; Kram JJF; Kamelle SA
    Gynecol Oncol; 2016 May; 141(2):199-205. PubMed ID: 26905210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study.
    Lee KB; Ki KD; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Jeong DH; Kim KT
    Ann Surg Oncol; 2009 Oct; 16(10):2882-7. PubMed ID: 19484311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
    Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group.
    Ouldamer L; Bendifallah S; Body G; Canlorbe G; Touboul C; Graesslin O; Raimond E; Collinet P; Coutant C; Lavoué V; Lévêque J; Daraï E; Ballester M;
    Ann Surg Oncol; 2017 Jun; 24(6):1660-1666. PubMed ID: 28058558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrioid adenocarcinoma of the uterus: surgico-pathological correlations and role of pelvic lymphadenectomy.
    Chee JJ; Ho TH; Tay EH; Low JJ; Yam KL
    Ann Acad Med Singap; 2003 Sep; 32(5):670-5. PubMed ID: 14626800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L1 Cell Adhesion Molecule (L1CAM) expression in endometrioid endometrial carcinomas: A possible pre-operative surrogate of lymph vascular space invasion.
    de Freitas D; Aguiar FN; Anton C; Bacchi CE; Carvalho JP; Carvalho FM
    PLoS One; 2018; 13(12):e0209294. PubMed ID: 30557309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram with potential clinical use to predict lymph node metastasis in endometrial cancer patients diagnosed incidentally by postoperative pathological assessment.
    Taşkın S; Şükür YE; Varlı B; Koyuncu K; Seval MM; Ateş C; Yüksel S; Güngör M; Ortaç F
    Arch Gynecol Obstet; 2017 Oct; 296(4):803-809. PubMed ID: 28762064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node metastasis probability in young patients eligible for conservative management of endometrial cancer.
    Gonthier C; Douhnai D; Koskas M
    Gynecol Oncol; 2020 Apr; 157(1):131-135. PubMed ID: 32139150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancer.
    Njølstad TS; Trovik J; Hveem TS; Kjæreng ML; Kildal W; Pradhan M; Marcickiewicz J; Tingulstad S; Staff AC; Haugland HK; Eraker R; Oddenes K; Rokne JA; Tjugum J; Lode MS; ; Amant F; Werner HM; Salvesen HB; Danielsen HE
    Br J Cancer; 2015 May; 112(10):1656-64. PubMed ID: 25897678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of endometrial sample and magnetic resonance imaging in the preoperative risk-stratification of endometrial carcinomas.
    Luomaranta A; Bützow R; Pauna AR; Leminen A; Loukovaara M
    Acta Obstet Gynecol Scand; 2015 Jan; 94(1):95-101. PubMed ID: 25287060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.